BioRestorative Therapies, Inc. (NV) Share Price
NASDAQ: BRTX | Micro CapBioRestorative Therapies, Inc. (NV) Stock Performance
BioRestorative Therapies, Inc. (NV) Share Price Chart
BioRestorative Therapies, Inc. (NV) Quarterly Profit & Loss
All figures in USD
BioRestorative Therapies, Inc. (NV) Annual Profit & Loss
All figures in USD
About BioRestorative Therapies, Inc. (NV)
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
BioRestorative Therapies, Inc. (NV) Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.42 | $1.53 | -34.33% |
Sep 2026 | $0.20 | $2.33 | +1,047.78% |
Aug 2026 | $0.21 | $0.20 | -0.98% |
Jul 2026 | $0.40 | $0.20 | -45.48% |
Jun 2026 | $0.43 | $0.38 | -17.54% |
May 2026 | $0.22 | $0.46 | +105.41% |
Apr 2026 | $0.27 | $0.22 | -19.27% |
Mar 2026 | $0.21 | $0.28 | +23.87% |
Feb 2026 | $1.17 | $0.22 | -79.82% |
Jan 2026 | $1.20 | $1.10 | -2.65% |
Dec 2025 | $1.06 | $1.13 | +9.18% |
Nov 2025 | $1.44 | $1.03 | -32.79% |